Mycostatin and Protein total decreased for Women aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Protein total decreased is found for women aged 50-59 who take Mycostatin (nystatin). This study is created by eHealthMe based on reports of 364 women aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

  • Time on Mycostatin when people have Protein total decreased
  • Top conditions
  • Top co-used drugs
  • Top other side effects

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

364 women aged 50-59 reported to have side effects when taking Mycostatin.
Among them, 1 person (0.27%) has Protein total decreased


What is Mycostatin?

Mycostatin has active ingredients of nystatin. eHealthMe is studying from 4,144 Mycostatin users. Check the latest studies of Mycostatin.

What is Protein total decreased?

Protein total decreased is found to be associated with 723 drugs and 933 conditions by eHealthMe. Check the latest studies of Protein total decreased.

Number of reports submitted per year:

Could Mycostatin cause Protein total decreased in women aged 50-59?

Time on Mycostatin when people have Protein total decreased *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Severity of Protein total decreased

n/a

How people recovered from Protein total decreased

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

  1. Oral Candidiasis (fungal infection of mouth): 1 person, 100.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 100.00%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

  1. Zanaflex: 1 person, 100.00%
  2. Wellbutrin: 1 person, 100.00%
  3. Cozaar: 1 person, 100.00%
  4. Cymbalta: 1 person, 100.00%
  5. Deltasone: 1 person, 100.00%
  6. Gilenya: 1 person, 100.00%
  7. Kadian: 1 person, 100.00%
  8. Klor-Con: 1 person, 100.00%
  9. Levothroid: 1 person, 100.00%
  10. Lioresal: 1 person, 100.00%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

  1. Visual Impairment: 1 person, 100.00%
  2. The Flu (the flu is caused by an influenza virus): 1 person, 100.00%
  3. Blood Chloride Increased: 1 person, 100.00%
  4. Blood Glucose Increased: 1 person, 100.00%
  5. Blood Potassium Decreased: 1 person, 100.00%
  6. Cervical Spinal Stenosis (narrowing of the spinal canal in the neck): 1 person, 100.00%
  7. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 100.00%
  8. Dry Mouth: 1 person, 100.00%
  9. Fatigue (feeling of tiredness): 1 person, 100.00%
  10. Headache (pain in head): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mycostatin and have Protein total decreased?

- Check whether Protein total decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, nystatin (the active ingredients of Mycostatin) and Mycostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: